Lupin Limited
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- India
- Registered address
- Unit-2, Plot No. 6B, Sector - 17, Special Economic Zone, Mihan, Nagpur, Maharashtra 441108, India (IND)
- Operations here
- manufacturepack
- FDA identifiers
- FEI 3015392060 · DUNS 675485014
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2025-09-16
Drugs this plant is listed as making
4 distinct drugs across 4 products name this site in their FDA label.
- Bumetanidein shortageLupin Pharmaceuticals, Inc.
- Ganirelix AcetateLupin Pharmaceuticals, Inc.
- GlucagonLupin Pharmaceuticals, Inc.
- Liraglutidein shortageLupin Pharmaceuticals, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.